4.5 Review

Fat grafting and stem cell enhanced fat grafting to the breast under oncological aspects - Recommendations for patient selection

Journal

BREAST
Volume 22, Issue 5, Pages 579-584

Publisher

CHURCHILL LIVINGSTONE
DOI: 10.1016/j.breast.2013.05.006

Keywords

Adipose derived stem cells; Vascular stromal fraction; Liposuction; Fat transfer; Liposculpture; Breast reconstruction; Breast augmentation; Breast cancer; Stem cell enhancement

Funding

  1. Swiss National Science Foundation [SNF 310030_127577]
  2. Swiss National Science Foundation (SNF) [310030_127577] Funding Source: Swiss National Science Foundation (SNF)

Ask authors/readers for more resources

Reconstructive and aesthetic fat grafting has been introduced to the breast level over the last years. The safety of such procedures has so far not been completely clarified. The concept has now been refined to stem cell enhanced fat grafting. However beside the promise of using adult stem cells in terms of tissue rejuvenation and augmentation, scar treatment and reconstruction, the variance of adipose stem cell function - including angiogenetic, antiapoptotic, immunomodulatory, chemotactic and anti-scarring potential - raises new scepsis about oncological safety. Herein we reviewed experimental and clinical data on fat grafting and stem cell enhanced fat grafting addressing surgical promise and oncological concerns. Based on these data we suggest clinical criteria for patient selection undergoing fat grafting for aesthetic or reconstructive reasons based on their individual breast cancer risk. (C) 2013 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available